Market Overview:
The global human coagulation instrument market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for automated and semi-automated coagulation instruments from biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, research and academic institutes, and others. Additionally, the growing prevalence of diseases such as hemophilia is also contributing to the growth of this market. However, factors such as high cost of automated coagulation instruments may restrain the growth of this market during the forecast period.
Product Definition:
Human coagulation instrument is a device that is used to control bleeding by using pressure and/or a hemostatic agent. The importance of human coagulation instrument is that it can help stop or slow down the bleeding process, which can potentially save someone's life.
Automated Coagulation Instrument:
Automated Coagulation Instrument (ACI) is a device used for measuring the coagulation factors in patients. It helps to evaluate the bleeding diathesis and platelet count in patients. The automated coagulation instrument market is expected to witness lucrative growth over the forecast period owing to increasing demand for point of care diagnostics, growing geriatric population base, rising prevalence of lifestyle diseases & cancer coupled with increasing government initiatives towards creating awareness about hemostasis among people.
Semi Auto Coagulation Instrument:
Semi auto coagulation instrument is a device which can be used as both human blood analyzer and manual blood donor machine. It helps in measuring different components of hemoglobin such as oxygen saturation level, total protein, and hematocrit level. These devices are majorly used for the diagnosis of anemia caused due to chronic diseases such as cancer, kidney disease or any other disease that affects the red blood cells production.
Application Insights:
The research and academic institutes segment dominated the global human coagulation instrument market in 2017, accounting for a revenue share of over 30%. The segment is expected to witness significant growth owing to an increase in the number of R&D laboratories across the globe. In addition, growing government support for advanced medical equipment is anticipated to boost product demand.
Coagulation plays a major role in various applications such as biotechnology & pharmaceutical companies, hospitals and diagnostic laboratories, research & academic institutes among others. Various factors such as high accuracy rate coupled with low risk of contamination make it preferred choice for these application segments. However, other alternatives such as electrophoresis are also used by different industries due to their lower cost compared to automated coagulation instruments (ACI).
Automated coagulation instrument accounted for more than 50% share of overall revenue in 2017 due its wide application across multiple industries including biotechnology.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable government initiatives, increasing healthcare expenditure, and presence of key players in this region. For instance, according to the World Health Organization (WHO), health expenditure as a percentage of GDP is around 9% for North America compared to 5% for developing regions. In addition, technological advancements coupled with high adoption rate of advanced products are also contributing towards regional growth.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding available treatment options & availability of these devices in emerging countries like India & China etc.). Moreover, rising prevalence of cardiovascular diseases (CVDs) due to unhealthy lifestyles will drive demand further during the forecast period.
Growth Factors:
- Increasing incidence of bleeding disorders and other coagulation-related disorders
- Growing demand for minimally invasive surgeries
- Rising number of trauma cases and accidents
- Increasing use of blood transfusions and other coagulation therapies
- Technological advancements in human coagulation instrumentation
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Coagulation Instrument Market Research Report
By Type
Automated Coagulation Instrument, Semi Auto Coagulation Instrument
By Application
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes
By Companies
Sysmex Corporation, Instrumentation Laboratory Company (Werfen), Stago Group (HemoSonics), Roche Diagnostics, Haemonetics, Mindray, HORIBA Medical, Grifols, Sekisui Medical, TECO Medical Instruments Production, Rayto, Succeeder, SUNBIO, Behnk Elektronik
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Human Coagulation Instrument Market Report Segments:
The global Human Coagulation Instrument market is segmented on the basis of:
Types
Automated Coagulation Instrument, Semi Auto Coagulation Instrument
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sysmex Corporation
- Instrumentation Laboratory Company (Werfen)
- Stago Group (HemoSonics)
- Roche Diagnostics
- Haemonetics
- Mindray
- HORIBA Medical
- Grifols
- Sekisui Medical
- TECO Medical Instruments Production
- Rayto
- Succeeder
- SUNBIO
- Behnk Elektronik
Highlights of The Human Coagulation Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automated Coagulation Instrument
- Semi Auto Coagulation Instrument
- By Application:
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Coagulation Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A human coagulation instrument is a medical device used to measure the amount of blood that is clotting.
Some of the key players operating in the human coagulation instrument market are Sysmex Corporation, Instrumentation Laboratory Company (Werfen), Stago Group (HemoSonics), Roche Diagnostics, Haemonetics, Mindray, HORIBA Medical, Grifols, Sekisui Medical, TECO Medical Instruments Production, Rayto, Succeeder, SUNBIO, Behnk Elektronik.
The human coagulation instrument market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Coagulation Instrument Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Coagulation Instrument Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Coagulation Instrument Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Coagulation Instrument Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Coagulation Instrument Market Size & Forecast, 2018-2028
4.5.1 Human Coagulation Instrument Market Size and Y-o-Y Growth
4.5.2 Human Coagulation Instrument Market Absolute $ Opportunity
Chapter 5 Global Human Coagulation Instrument Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Human Coagulation Instrument Market Size Forecast by Type
5.2.1 Automated Coagulation Instrument
5.2.2 Semi Auto Coagulation Instrument
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Human Coagulation Instrument Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Human Coagulation Instrument Market Size Forecast by Applications
6.2.1 Biotechnology and Pharmaceutical Companies
6.2.2 Hospitals and Diagnostic Laboratories
6.2.3 Research and Academic Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Coagulation Instrument Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Coagulation Instrument Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Human Coagulation Instrument Analysis and Forecast
9.1 Introduction
9.2 North America Human Coagulation Instrument Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Human Coagulation Instrument Market Size Forecast by Type
9.6.1 Automated Coagulation Instrument
9.6.2 Semi Auto Coagulation Instrument
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Human Coagulation Instrument Market Size Forecast by Applications
9.10.1 Biotechnology and Pharmaceutical Companies
9.10.2 Hospitals and Diagnostic Laboratories
9.10.3 Research and Academic Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Human Coagulation Instrument Analysis and Forecast
10.1 Introduction
10.2 Europe Human Coagulation Instrument Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Human Coagulation Instrument Market Size Forecast by Type
10.6.1 Automated Coagulation Instrument
10.6.2 Semi Auto Coagulation Instrument
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Human Coagulation Instrument Market Size Forecast by Applications
10.10.1 Biotechnology and Pharmaceutical Companies
10.10.2 Hospitals and Diagnostic Laboratories
10.10.3 Research and Academic Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Human Coagulation Instrument Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Human Coagulation Instrument Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Human Coagulation Instrument Market Size Forecast by Type
11.6.1 Automated Coagulation Instrument
11.6.2 Semi Auto Coagulation Instrument
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Human Coagulation Instrument Market Size Forecast by Applications
11.10.1 Biotechnology and Pharmaceutical Companies
11.10.2 Hospitals and Diagnostic Laboratories
11.10.3 Research and Academic Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Human Coagulation Instrument Analysis and Forecast
12.1 Introduction
12.2 Latin America Human Coagulation Instrument Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Human Coagulation Instrument Market Size Forecast by Type
12.6.1 Automated Coagulation Instrument
12.6.2 Semi Auto Coagulation Instrument
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Human Coagulation Instrument Market Size Forecast by Applications
12.10.1 Biotechnology and Pharmaceutical Companies
12.10.2 Hospitals and Diagnostic Laboratories
12.10.3 Research and Academic Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Human Coagulation Instrument Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Human Coagulation Instrument Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Human Coagulation Instrument Market Size Forecast by Type
13.6.1 Automated Coagulation Instrument
13.6.2 Semi Auto Coagulation Instrument
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Human Coagulation Instrument Market Size Forecast by Applications
13.10.1 Biotechnology and Pharmaceutical Companies
13.10.2 Hospitals and Diagnostic Laboratories
13.10.3 Research and Academic Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Coagulation Instrument Market: Competitive Dashboard
14.2 Global Human Coagulation Instrument Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sysmex Corporation
14.3.2 Instrumentation Laboratory Company (Werfen)
14.3.3 Stago Group (HemoSonics)
14.3.4 Roche Diagnostics
14.3.5 Haemonetics
14.3.6 Mindray
14.3.7 HORIBA Medical
14.3.8 Grifols
14.3.9 Sekisui Medical
14.3.10 TECO Medical Instruments Production
14.3.11 Rayto
14.3.12 Succeeder
14.3.13 SUNBIO
14.3.14 Behnk Elektronik
